Page last updated: 2024-09-02

tanshinone and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

tanshinone has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies

Compound Research Comparison

Studies
(tanshinone)
Trials
(tanshinone)
Recent Studies (post-2010)
(tanshinone)
Studies
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Trials
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
1,445101,0337930110

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, MQ; Jin, ZX; Li, GR; Li, ZC; Luo, Y; Sun, DD; Wang, HC; Wang, XB1

Other Studies

1 other study(ies) available for tanshinone and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

ArticleYear
Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.
    European journal of pharmacology, 2008, Aug-20, Volume: 590, Issue:1-3

    Topics: Abietanes; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guanylate Cyclase; Heart; Humans; KCNQ1 Potassium Channel; Kv1.5 Potassium Channel; Nitric Oxide Donors; Oxadiazoles; Phenanthrenes; Potassium Channels, Voltage-Gated; Quinoxalines

2008